about
Novel Perspectives in Redox Biology and Pathophysiology of Failing Myocytes: Modulation of the Intramyocardial Redox Milieu for Therapeutic Interventions-A Review Article from the Working Group of Cardiac Cell Biology, Italian Society of CardiologyLong-QT syndrome: from genetics to managementTransient outward current (I(to)) gain-of-function mutations in the KCND3-encoded Kv4.3 potassium channel and Brugada syndromeGain-of-function mutation S422L in the KCNJ8-encoded cardiac K(ATP) channel Kir6.1 as a pathogenic substrate for J-wave syndromesLeft cardiac sympathetic denervation for catecholaminergic polymorphic ventricular tachycardiaPrevalence of long-QT syndrome gene variants in sudden infant death syndromeCommon variants at SCN5A-SCN10A and HEY2 are associated with Brugada syndrome, a rare disease with high risk of sudden cardiac deathGenetic association study of QT interval highlights role for calcium signaling pathways in myocardial repolarizationA novel disease gene for Brugada syndrome: sarcolemmal membrane-associated protein gene mutations impair intracellular trafficking of hNav1.5.The Jervell and Lange-Nielsen syndrome: natural history, molecular basis, and clinical outcome.Clinical implications for patients with long QT syndrome who experience a cardiac event during infancy.Mutation-specific risk in two genetic forms of type 3 long QT syndrome.Novel calmodulin mutations associated with congenital arrhythmia susceptibility.Clinical Management of Catecholaminergic Polymorphic Ventricular Tachycardia: The Role of Left Cardiac Sympathetic Denervation.Impact of clinical and genetic findings on the management of young patients with Brugada syndrome.Congenital short QT syndrome.Who are the long-QT syndrome patients who receive an implantable cardioverter-defibrillator and what happens to them?: data from the European Long-QT Syndrome Implantable Cardioverter-Defibrillator (LQTS ICD) Registry.Not all beta-blockers are equal in the management of long QT syndrome types 1 and 2: higher recurrence of events under metoprololAKAP9 is a genetic modifier of congenital long-QT syndrome type 1Autonomic control of heart rate and QT interval variability influences arrhythmic risk in long QT syndrome type 1.Multiscale complexity analysis of the cardiac control identifies asymptomatic and symptomatic patients in long QT syndrome type 1.Role of common and rare variants in SCN10A: results from the Brugada syndrome QRS locus gene discovery collaborative study.A novel rare variant in SCN1Bb linked to Brugada syndrome and SIDS by combined modulation of Na(v)1.5 and K(v)4.3 channel currents.Vagal reflexes following an exercise stress test: a simple clinical tool for gene-specific risk stratification in the long QT syndrome.Torsades de pointes following acute myocardial infarction: evidence for a deadly link with a common genetic variant.The E1784K mutation in SCN5A is associated with mixed clinical phenotype of type 3 long QT syndrome.Mutation analysis of the phospholamban gene in 315 South Africans with dilated, hypertrophic, peripartum and arrhythmogenic right ventricular cardiomyopathies.Spectrum and prevalence of mutations involving BrS1- through BrS12-susceptibility genes in a cohort of unrelated patients referred for Brugada syndrome genetic testing: implications for genetic testing.Characterization of SEMA3A-encoded semaphorin as a naturally occurring Kv4.3 protein inhibitor and its contribution to Brugada syndrome.The genetics underlying acquired long QT syndrome: impact for genetic screeningIon channel diseases in children: manifestations and management.Malignant perinatal variant of long-QT syndrome caused by a profoundly dysfunctional cardiac sodium channelCalmodulin mutations associated with recurrent cardiac arrest in infants.Long QT syndrome-associated mutations in intrauterine fetal death.Identification of a KCNQ1 polymorphism acting as a protective modifier against arrhythmic risk in long-QT syndromeFGF12 is a candidate Brugada syndrome locus.NOS1AP is a genetic modifier of the long-QT syndrome.Propranolol prevents life-threatening arrhythmias in LQT3 transgenic mice: implications for the clinical management of LQT3 patientsPrevalence of the congenital long-QT syndrome.Genetic predisposition to sudden cardiac death.
P50
Q26765793-A3B4982B-F5BF-479C-B144-937B87312632Q26823298-D1E2DECF-50F9-4A1A-B721-DDAF8CD91623Q28118648-1E5E7498-4832-411C-8289-F943F7392562Q28118815-C714FD38-D0B4-4715-B4F8-B87133D0EB7AQ28279395-F593008E-F11E-4C1D-A1E6-A8F522D9130AQ28282448-A6FEAB3F-46AE-46AA-9A80-2B6307C6CB7AQ28294931-3DF48292-CBE4-4DB3-B211-1C6E70AA516EQ28654771-131E76F0-FC1B-4B98-8FB1-3CB82BE35013Q29347544-90306659-6296-4D01-97D8-0A1F9653EAB5Q33153549-A2C71086-CE42-4CDC-BACE-A1BBFB51BFC4Q33157716-A71BAD8B-425E-45B2-9F9F-91B5ED67074CQ33158299-102F43C6-16B6-420A-8053-09A7EC0782D7Q33164413-DE7E1163-FC2D-4AD6-9BE4-90CF7BD96EB7Q33165777-A57F50DE-24AC-42B6-A335-EB90B129BF83Q33166854-7490C20F-4774-40EE-A14D-47B614F882F4Q33609619-919FE7DA-5335-40FE-8EA4-17FDDF6EF24EQ33691189-7A1F7BBC-1A18-4FB3-8862-05BD07C02C08Q34307224-FED7E2B3-9319-458E-9D10-0E755778443AQ34734831-746E7648-D462-451F-8C8D-2CBC4F297A73Q35033272-A153710D-85FF-4261-A553-5AA511548BEDQ35140471-2A2C45E5-57E8-43D3-BAC2-172FD6323B3EQ35661823-691C5140-E5CC-4E48-B73D-7B0FB743CDD0Q35907195-F97B6953-D3FE-472A-988D-7BAFFD3DB12CQ36467977-AD825CC9-79BE-4306-9B20-3D91C93915E6Q36593290-B194FDA5-3164-4D0E-AAA5-6C5650334ED6Q36597505-99EA2ACE-90FE-4F0D-9070-1D524B4D8B75Q36731937-A27D4AC5-A63A-44D8-9935-537AA948189DQ36761139-2B6F9454-7633-40A1-AAC0-AFA54C0ADE1BQ37002977-B74343A8-E0D4-4C05-9B86-D86460940591Q37023884-79AFE672-50B0-4EC3-8FDA-113AD054A113Q37125761-CDE09E23-6B62-4156-9930-503B27E81B36Q37301466-2981B889-4631-4FB7-883A-120B17DDFB04Q37327429-6F6BB76D-209A-4A18-9A3C-0668CADF39B2Q37367812-6A28931E-69F5-4D4B-9793-00D19EE4B7CBQ37396467-C46C5034-7231-4355-AAF2-42DDF68F84A0Q37407989-F0444A76-DB06-4185-9DE5-165A1FD28E1DQ37439194-A9D7D076-04F1-4C93-BC83-49BAC66D02B1Q37440443-3003B837-AB47-4D4B-B211-6732F8A0BF8FQ37442080-9575D3FF-D258-4F2A-ACD3-983D89B88565Q37811785-64D56408-91E3-40D6-A832-8513157F08FA
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Lia Crotti
@ast
Lia Crotti
@en
Lia Crotti
@es
Lia Crotti
@nl
type
label
Lia Crotti
@ast
Lia Crotti
@en
Lia Crotti
@es
Lia Crotti
@nl
altLabel
lia crotti
@en
prefLabel
Lia Crotti
@ast
Lia Crotti
@en
Lia Crotti
@es
Lia Crotti
@nl
P106
P21
P31
P496
0000-0001-8739-6527